Management of non-response to Hepatitis B re-vaccination
Our results demonstrate the rationale for offering additional vaccination with Fendrix® to HCWs when standard vaccination and repeated administration has not elicited an adequate immune response. Multi-centre evaluation of this vaccination strategy for non-responder HCWs should be considered to generate evidence for the most acceptable and efficacious approach.
Authors
- Anil Adisesh (ORCID: https://orcid.org/0000-0002-4973-8474)
- Prosenjit Giri (ORCID: https://orcid.org/0000-0001-9375-8117)
- Helen L Kroening
Institutions
- Dalhousie University (CA)
- Saint John Regional Hospital (CA)
- Northern General Hospital (GB)
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- UConn Health (US)
Publication Details
- Journal
- Occupational Medicine
- Published
- 2025-08-09
- DOI
- https://doi.org/10.1093/occmed/kqaf091
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00